1. Home
  2. TECX vs BSVN Comparison

TECX vs BSVN Comparison

Compare TECX & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.77

Market Cap

545.3M

Sector

N/A

ML Signal

HOLD

Logo Bank7 Corp.

BSVN

Bank7 Corp.

HOLD

Current Price

$44.80

Market Cap

384.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
BSVN
Founded
2019
2004
Country
United States
United States
Employees
60
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
545.3M
384.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
TECX
BSVN
Price
$29.77
$44.80
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$75.20
$53.33
AVG Volume (30 Days)
172.8K
8.9K
Earning Date
05-07-2026
04-14-2026
Dividend Yield
N/A
2.46%
EPS Growth
N/A
N/A
EPS
N/A
4.50
Revenue
N/A
N/A
Revenue This Year
N/A
$4.59
Revenue Next Year
N/A
$7.19
P/E Ratio
N/A
$9.77
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$33.92
52 Week High
$35.99
$50.10

Technical Indicators

Market Signals
Indicator
TECX
BSVN
Relative Strength Index (RSI) 49.76 67.62
Support Level $28.31 $42.53
Resistance Level $32.27 $43.91
Average True Range (ATR) 1.52 0.74
MACD -0.32 0.48
Stochastic Oscillator 28.83 67.79

Price Performance

Historical Comparison
TECX
BSVN

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About BSVN Bank7 Corp.

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

Share on Social Networks: